UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, today announced the ...
UTRECHT, The Netherlands--(BUSINESS WIRE)--InteRNA Technologies announced today that the first patient has been dosed in the first cohort of its first-in-human Phase I study with the Company’s lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results